Delivery Order SPE2DB22D1106-SPE2DB23FEQR5
Award Date 7/11/23
Potential Completion Date 7/12/23
Potential Value $1.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,218.90 delivery order to Amerisourcebergen Drug Corporation for the supply of 200-300mg Emtricitabine-Tenofovir tablets. The firm fixed price order is for 30 units of the HIV medication and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 9, 2023 to support DLA programs. No set aside designation or subcontractors were identified. The order was placed under an existing DLA pharmaceutical supply vehicle to...
- The Defense Logistics Agency awarded a $4,151.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 200-300mg Emtricitabine-Tenofovir tablets. The delivery order was issued under an existing prime vendor contract vehicle and calls for the delivery of a 30-day supply of the HIV medication to a Defense Logistics Agency location in Conshohocken, Pennsylvania by September 15, 2023. Amerisourcebergen will perform as the prime contractor, with no mention of major...
- The Defense Logistics Agency awarded a $692.76 delivery order to Amerisourcebergen Drug Corporation for the provision of 200-300mg emtricitabine-tenofovir combination tablets. The firm fixed price order calls for the delivery of 30 units of the HIV treatment medication to a location in Conshohocken, Pennsylvania, with performance required between July 17-18, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $4,239 to Amerisourcebergen Drug Corporation for the supply of 200-300mg Emtricitabine-Tenofovir disoproxil fumarate combination tablets in unit dose packaging of 30 tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 15-16, 2023. This delivery order was issued against the DLA's Pharmaceutical Prime Vendor...
- The Defense Logistics Agency awarded a $417,420 delivery order to Amerisourcebergen Drug Corporation for the supply of emtricitabine-tenofovir disoproxil fumarate combination tablets. The firm fixed price order calls for the delivery of 200-300mg tablets packaged in unit doses of 30 tablets to a facility in Conshohocken, Pennsylvania. Performance will take place between July 28 and July 31, 2023. The DLA manages the Department of Defense's global logistics operations and supply chain network,...
- The Defense Logistics Agency awarded a $188,460 delivery order to Amerisourcebergen Drug Corporation for the supply of emtricitabine-tenofovir disoproxil fumarate combination tablets. The firm fixed price order calls for the delivery of 200-300mg doses of the HIV/AIDS drug in unit-of-use packaging of 30 tablets. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from July 18 to July 19, 2023. No set aside provisions or...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $693 to Amerisourcebergen Drug Corporation for the supply of 200-300mg emtricitabine-tenofovir disoproxil fumarate combination tablets. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of 3 days from July 7 through July 10, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to ensure essential...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,823 to Amerisourcebergen Drug Corporation for the supply of 200-300mg emtricitabine-tenofovir combination tablets. The delivery order was issued against an existing prime vendor contract vehicle and calls for the delivery of 30 bottles of the HIV pre-exposure prophylaxis medication to a DLA facility in Conshohocken, Pennsylvania by June 30, 2023. Amerisourcebergen will perform as the prime...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $12,937 to Amerisourcebergen Drug Corporation for the supply of 200-300mg Emtricitabine-Tenofovir disoproxil fumarate combination tablets in unit dose packages of 30 tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 25, 2023 under the terms of the order. The Defense Logistics Agency...
- The Defense Logistics Agency awarded a $785 delivery order to Amerisourcebergen Drug Corporation for the supply of emtricitabine-tenofovir disoproxil fumarate 200-300mg tablets. The firm fixed price order calls for the delivery of 30 count bottles of the HIV/AIDS drug to a facility in Conshohocken, Pennsylvania by July 3, 2023. Amerisourcebergen will perform as the prime contractor, with no mention of major subcontractors. The Defense Logistics Agency manages the Department of Defense's global...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB23FEQR5Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,652 to Amerisourcebergen Drug Corporation for the supply of 200-300mg emtricitabine-tenofovir combination tablets. The order, placed under an existing prime vendor contract vehicle, calls for the delivery of 30 bottles of the HIV/AIDS medication to a DLA facility in Conshohocken, Pennsylvania by July 12, 2023. No subcontractors or set-aside designations were indicated. The award supports DLA's mission to provide pharmaceuticals and medical supplies to the Department of Defense and other federal agencies to ensure military readiness and public health.
Generated 12/20/23, 2:17 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/11/23 |